Basic anatomical, and physiological differences between species should be considered when choosing combinations for use in models of hepatic xenotransplantation: An investigation of the guinea pig-to-rat combination

Transplantation

Volumn 66, Issue 1, 1998, Pages 112-141

  Delriviere, Luc D ^a   Havaux, Xavier ^b   Gibbs, Paul ^a   Gianello, Pierre R ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTICLE; GUINEA PIG; LIVER BLOOD FLOW; LIVER TRANSPLANTATION; NONHUMAN; ORGAN TRANSPLANTATION; PORTAL VEIN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; XENOTRANSPLANTATION;

ANIMALS; GUINEA PIGS; ISCHEMIA; LIVER CIRCULATION; LIVER TRANSPLANTATION; MALE; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; RATS; RATS, INBRED STRAINS; REGIONAL BLOOD FLOW; REPERFUSION; SPECIES SPECIFICITY; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032528032     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199807150-00017     Document Type: Article

References (12)

1. Qunibi WY, Barri Y, Alfurayh O, et al. Kaposi's sarcoma in renal transplant recipients: a report on 26 cases from a single institution. Transplant Proc 1993; 25: 1402.
2. Margolius L, Stein M, Spencer D, Bezwoda WR. Kaposi's sarcoma in renal transplant recipients: experience at Johannesburg Hospital, 1966-1989. S Afr Med J 1994; 84: 16.
3. Montagnino G, Bencini PL, Tarantino A, Caputo R, Ponticelli C. Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases. Am J Nephrol 1994; 14: 121.
4. Penn I. Cancers following cyclosporin therapy. Transplantation 1987; 43: 32.
5. Aguado S, Tejada F, Gomez E, et al. Cytomegaloviraemia and T cell subpopulations in renal transplant patients. Nephrol Dial Transplant 1995; 10: 120.
6. Labalette M, Salez F, Pruvot FR, Noel C, Dessaint JP. CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CDS+ CD57-subset and its progressive replacement by CD8+ CD57+ T cells. Clin Exp Immunol 1994; 95: 465.
7. Laupacis A. Complications of cyclosporine therapy: a comparison to azathioprine. In: Kahan BD, ed. Cyclosporine: biological activity and clinical applications. Orlando: Grune & Stratton, 1983: 532.
8. Ziegler JL. Kaposi's sarcoma: introduction and overview. J AIDS 1990; 3: S1.
9. Gallo RC. Mechanisms of disease induction by HIV. J AIDS 1990; 3: 380.
10. Salahuddin SZ, Nakamura S, Biberfeld P, et al. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science 1988; 242: 430.
11. Qunibi W, Akhtar M, Sheth K, et al. Kaposi's sarcoma: the most common tumor after renal transplantation in Saudi Arabia. Am J Med 1988; 84: 225.
12. Chen N, Gao Q, Field EH. Prevention of Th1 response is critical for tolerance. Transplantation 1996; 61: 1076.